Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer

Immune-checkpoint inhibitors (ICI) targeting programmed cell death 1 (PD-1) and its ligand 1 (PD-L1) have quickly changed the treatment landscape in advanced non-small cell lung cancer. However, any patient treated with an immune checkpoint inhibitor is at risk for immune-related adverse events (irA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yao, Wang, Yimeng, Yu, Jinming, Meng, Xiangjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520566/
https://www.ncbi.nlm.nih.gov/pubmed/36189237
http://dx.doi.org/10.3389/fimmu.2022.998516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520566/
https://www.ncbi.nlm.nih.gov/pubmed/36189237
http://dx.doi.org/10.3389/fimmu.2022.998516

Ejemplares similares